Evaluating the consequences of rheumatoid arthritis

Area of Science:

• Health Economics
• Patient-Reported Outcomes

Background:

• Cost-effectiveness analysis (CEA) relies on utility values to assess health interventions.
• Discrepancies exist between patient and non-patient utility valuations for illness consequences.
• Societal versus patient perspectives in CEA remain a key debate.

Purpose of the Study:

• To compare utility values for rheumatoid arthritis (RA) consequences between patients and non-patients.
• To explore how differing perspectives influence CEA inputs.
• To identify specific areas of divergence in valuing health states.

Main Methods:

• Utilized data from a discrete choice experiment (DCE).
• Recruited both rheumatoid arthritis (RA) patients and a general non-patient population.
• Analyzed part-worth utilities for symptoms like pain, fatigue, and functional limitations, and the ability to work.

Main Results:

• Patients and non-patients reported similar utility values for pain, fatigue, and functional limitations in RA.
• Non-patients significantly undervalued the utility of being able to work compared to RA patients.
• This highlights a specific divergence in valuing a key aspect of daily functioning.

Conclusions:

• While general RA symptom severity is valued similarly, the ability to work presents a significant valuation gap.
• These findings have implications for resource allocation in healthcare and the design of CEA.
• Incorporating patient-specific utility values, particularly for work, may improve CEA accuracy for RA.